AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP lists 2 GLP-1 packages in the FDA NDC directory, covering exenatide.
By Sam Reed · Founder and data lead
AstraZeneca Pharmaceuticals LP appears on 2 GLP-1 packages in the FDA National Drug Code directory, covering exenatide. The labeler is the firm whose name is on the package. It is not necessarily the manufacturer, and it is never the telehealth programme that sells you the prescription.
The listing
Every package it lists
Source: FDA National Drug Code directory. A listing is a registration, not an FDA endorsement of the product.
Data sources · cited with retrieval dates
- FDA warning lettersPublished compliance actions, updated weekly
- FDA registered outsourcing facilities503B register, with inspection and enforcement status
- FDA National Drug Code directoryLabeler, product and package listings
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.